"We've set up the largest ever Lassa fever epidemiology study, which started in Nigeria in the year 2020.

We have made major investments in the development of vaccines, together with the NCDC and other partners.

Our aim should be to achieve equitable vaccine development and distribution"

- Dr Richard Hatchett, CEO, Coalition for Epidemic Preparedness Innovations

#NiCAFE2021